NCT03507751View on ClinicalTrials.gov

Pharmacokinetics of Meropenem During High-dose CRRT

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

April 2, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

February 2, 2019

Conditions
InfectionRenal Failure
Interventions
DRUG

Meropenem

1.0 gram of meropenem given intravenously every 8 hours

DEVICE

CRRT

Continuous renal replacement therapy for three days

Trial Locations (1)

10- 561

Oddział Kliniczny Anestezjologii i Intensywnej Terapii, Wojewódzki Szpital Specjalistyczny w Olsztynie, Olsztyn

All Listed Sponsors
collaborator

University of Warmia and Mazury in Olsztyn

OTHER

lead

Medical University of Lublin

OTHER

NCT03507751 - Pharmacokinetics of Meropenem During High-dose CRRT | Biotech Hunter | Biotech Hunter